What is TARS stock price today?

Visit our real-time dashboard for the current TARS stock price and live market data.

Is TARS stock going up or down today?

TARS stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy TARS stock now?

The decision to buy TARS depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is TARS a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for TARS based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is TARS stock overvalued or undervalued?

Use our DCF valuation calculator to determine if TARS is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is TARS's P/E ratio?

P/E ratio data for TARS will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is TARS's market cap?

TARS (Tarsus Pharmaceuticals Inc) has a market capitalization of $2.66 billion, making it a small-cap stock.

What is TARS's price to book ratio?

TARS trades at a price-to-book (P/B) ratio of 7.71, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does TARS pay dividends?

TARS does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is TARS's dividend yield?

TARS does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is TARS stock a good long-term investment?

TARS's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is TARS's revenue growth rate?

Revenue growth data for TARS is available on our dashboard with detailed financial statement analysis.

Profitability metrics for TARS are available on our dashboard with complete income statement analysis.

What are the risks of investing in TARS?

Key risks for TARS include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does TARS compare to its competitors?

Compare TARS to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize TARS's performance and positioning.

What is TARS's stock price target for 2026?

Visit our prediction page for AI-powered price targets for TARS with bull, base, and bear case scenarios.

What do analysts say about TARS?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for TARS. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is TARS's next earnings report?

TARS reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

TARS - Tarsus Pharmaceuticals Inc

NYSE * Healthcare * Biotechnology

$0.00

+$0.00 (+0.00%)

About Tarsus Pharmaceuticals Inc

Tarsus Pharmaceuticals Inc (TARS) common stock

Price Chart

Loading chart...

TARS Key Statistics

Market Cap

$2.66B

P/B Ratio

7.71

How TARS Compares to Peers

TARS is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
TARS(This stock)	$2.66B	N/A	0%	0.0%	-
AMGNAmgen Inc	$188.67B	24.3	0%	0.0%	vs AMGN
GILDGilead Sciences	$160.15B	17.5	0%	0.0%	vs GILD
VRTXVertex Pharmaceuticals	$106.87B	29.7	0%	0.0%	vs VRTX
REGNRegeneron Pharmaceuticals	$59.10B	13.9	0%	0.0%	vs REGN
BIIBBiogen Inc	$29.33B	21.4	0%	0.0%	vs BIIB

Data Updated: July 16, 2026 at 4:05 PM EDT

Ready to invest in TARS?

Commission-free trading available. Affiliate links.

TARS Lician Score

10% confidence

6.0/10

Good

TARS has a Lician Score of 6/10 (Good). Strengths: Growth.

value

5.0

growth

9.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates TARSacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

TARS Financial Snowflake

5-axis analysis across key investment dimensions

5.8/10

Neutral

5.0

Value

Valuation vs. sector peers

9.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for TARS

Dashboard

Enter a ticker to analyze